Annual CFF
$0.00
+$111.00 K+100.00%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual cash flow from financing activities is $0.00, with the most recent change of +$111.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, AMPE annual CFF has fallen by -$25.61 million (-100.00%).
- AMPE annual CFF is now -100.00% below its all-time high of $68.93 million, reached on December 31, 2014.
Performance
AMPE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly cash flow from financing activities is $0.00, unchanged on December 31, 2023.
- Over the past year, AMPE quarterly CFF has stayed the same.
- AMPE quarterly CFF is now -100.00% below its all-time high of $63.44 million, reached on March 31, 2014.
Performance
AMPE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 8, 2025, AMPE TTM cash flow from financing activities is $0.00, unchanged on December 31, 2023.
- Over the past year, AMPE TTM CFF has increased by +$111.00 thousand (+100.00%).
- AMPE TTM CFF is now -100.00% below its all-time high of $89.81 million, reached on March 31, 2014.
Performance
AMPE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMPE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | +100.0% |
| 3 y3 years | -100.0% | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% | -100.0% |
AMPE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| 5 y | 5-year | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Ampio Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | -$111.00 K(-100.4%) | $0.00(0.0%) | -$111.00 K(-100.5%) |
| Sep 2022 | - | $0.00(0.0%) | $20.37 M(-2.4%) |
| Jun 2022 | - | $0.00(-100.0%) | $20.86 M(-25.3%) |
| Mar 2022 | - | -$111.00 K(-100.5%) | $27.93 M(-9.1%) |
| Dec 2021 | $30.73 M(+20.0%) | $20.48 M(+4037.0%) | $30.73 M(+45.4%) |
| Sep 2021 | - | $495.00 K(-93.0%) | $21.13 M(-24.3%) |
| Jun 2021 | - | $7.07 M(+163.3%) | $27.91 M(+0.2%) |
| Mar 2021 | - | $2.69 M(-75.3%) | $27.86 M(+8.8%) |
| Dec 2020 | $25.61 M(+78.4%) | $10.88 M(+49.6%) | $25.61 M(+42.5%) |
| Sep 2020 | - | $7.27 M(+3.6%) | $17.97 M(+68.0%) |
| Jun 2020 | - | $7.02 M(+1509.4%) | $10.70 M(-27.5%) |
| Mar 2020 | - | $436.00 K(-86.6%) | $14.77 M(+2.9%) |
| Dec 2019 | $14.35 M(+18.8%) | $3.25 M(>+9900.0%) | $14.35 M(+15.5%) |
| Sep 2019 | - | $0.00(-100.0%) | $12.42 M(-36.9%) |
| Jun 2019 | - | $11.09 M(>+9900.0%) | $19.69 M(+118.8%) |
| Mar 2019 | - | $20.00 K(-98.5%) | $9.00 M(-25.5%) |
| Dec 2018 | $12.08 M(-18.4%) | $1.32 M(-81.9%) | $12.08 M(-38.9%) |
| Sep 2018 | - | $7.26 M(+1737.8%) | $19.77 M(+57.9%) |
| Jun 2018 | - | $395.30 K(-87.3%) | $12.52 M(-30.0%) |
| Mar 2018 | - | $3.10 M(-65.6%) | $17.90 M(+21.0%) |
| Dec 2017 | $14.79 M(+319.3%) | $9.01 M(>+9900.0%) | $14.79 M(+153.0%) |
| Sep 2017 | - | $12.40 K(-99.8%) | $5.85 M(-37.1%) |
| Jun 2017 | - | $5.77 M(>+9900.0%) | $9.30 M(+163.5%) |
| Mar 2017 | - | $0.00(-100.0%) | $3.53 M(0.0%) |
| Dec 2016 | $3.53 M(-83.3%) | $65.50 K(-98.1%) | $3.53 M(-82.1%) |
| Sep 2016 | - | $3.46 M(>+9900.0%) | $19.76 M(-6.7%) |
| Jun 2016 | - | $0.00(0.0%) | $21.18 M(+0.1%) |
| Mar 2016 | - | $0.00(-100.0%) | $21.16 M(0.0%) |
| Dec 2015 | $21.16 M | $16.30 M(+234.2%) | $21.16 M(+103.9%) |
| Sep 2015 | - | $4.88 M(<-9900.0%) | $10.38 M(+89.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$18.70 K(<-9900.0%) | $5.47 M(-0.3%) |
| Mar 2015 | - | $0.00(-100.0%) | $5.49 M(-92.0%) |
| Dec 2014 | $68.93 M(+134.3%) | $5.52 M(<-9900.0%) | $68.93 M(+8.2%) |
| Sep 2014 | - | -$33.00 K(<-9900.0%) | $63.71 M(-28.2%) |
| Jun 2014 | - | $0.00(-100.0%) | $88.74 M(-1.2%) |
| Mar 2014 | - | $63.44 M(>+9900.0%) | $89.81 M(+205.2%) |
| Dec 2013 | $29.43 M(+83.7%) | $295.50 K(-98.8%) | $29.43 M(+1.0%) |
| Sep 2013 | - | $25.01 M(+2241.6%) | $29.13 M(+49.5%) |
| Jun 2013 | - | $1.07 M(-65.1%) | $19.49 M(+2.4%) |
| Mar 2013 | - | $3.06 M(>+9900.0%) | $19.04 M(+18.8%) |
| Dec 2012 | $16.02 M(-19.7%) | $0.00(-100.0%) | $16.02 M(-34.7%) |
| Sep 2012 | - | $15.37 M(+2386.3%) | $24.52 M(+162.3%) |
| Jun 2012 | - | $618.00 K(+1574.8%) | $9.35 M(-34.6%) |
| Mar 2012 | - | $36.90 K(-99.6%) | $14.31 M(-28.3%) |
| Dec 2011 | $19.94 M(+517.9%) | $8.50 M(+4276.7%) | $19.94 M(+55.3%) |
| Sep 2011 | - | $194.20 K(-96.5%) | $12.84 M(-2.4%) |
| Jun 2011 | - | $5.57 M(-1.7%) | $13.16 M(+67.0%) |
| Mar 2011 | - | $5.67 M(+305.0%) | $7.89 M(+144.3%) |
| Dec 2010 | $3.23 M(+123.5%) | $1.40 M(+172.0%) | $3.23 M(+47.2%) |
| Sep 2010 | - | $515.00 K(+74.4%) | $2.19 M(+30.4%) |
| Jun 2010 | - | $295.30 K(-70.9%) | $1.68 M(-31.4%) |
| Mar 2010 | - | $1.02 M(+177.3%) | $2.45 M(+69.9%) |
| Dec 2009 | $1.44 M(+3602.3%) | $366.50 K(+9805.4%) | $1.44 M(+32.9%) |
| Sep 2009 | - | $3700.00(-99.7%) | $1.09 M(+0.3%) |
| Jun 2009 | - | $1.07 M(>+9900.0%) | $1.08 M(+3392.3%) |
| Mar 2009 | - | $7000.00(-22.2%) | $31.00 K(-20.5%) |
| Dec 2008 | $39.00 K(+96.0%) | $9000.00(>+9900.0%) | $39.00 K(+30.0%) |
| Sep 2008 | - | $0.00(-100.0%) | $30.00 K(+2.0%) |
| Jun 2008 | - | $15.00 K(0.0%) | $29.40 K(-15.8%) |
| Mar 2008 | - | $15.00 K(>+9900.0%) | $34.90 K(+75.4%) |
| Dec 2007 | $19.90 K(+1890.0%) | $0.00(-100.0%) | $19.90 K(0.0%) |
| Sep 2007 | - | -$600.00(-102.9%) | $19.90 K(-2.9%) |
| Jun 2007 | - | $20.50 K(>+9900.0%) | $20.50 K(>+9900.0%) |
| Mar 2007 | - | $0.00 | $0.00 |
| Dec 2006 | $1000.00 | - | - |
FAQ
- What is Ampio Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual CFF year-on-year change?
- What is Ampio Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly CFF year-on-year change?
- What is Ampio Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM CFF year-on-year change?
What is Ampio Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AMPE is $0.00
What is the all time high annual CFF for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual cash flow from financing activities is $68.93 M
What is Ampio Pharmaceuticals annual CFF year-on-year change?
Over the past year, AMPE annual cash flow from financing activities has changed by +$111.00 K (+100.00%)
What is Ampio Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AMPE is $0.00
What is the all time high quarterly CFF for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly cash flow from financing activities is $63.44 M
What is Ampio Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AMPE quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Ampio Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AMPE is $0.00
What is the all time high TTM CFF for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM cash flow from financing activities is $89.81 M
What is Ampio Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AMPE TTM cash flow from financing activities has changed by +$111.00 K (+100.00%)